ETC-1002 (Bempedoic acid) for the management of hyperlipidemia: from preclinical studies to phase 3 trials-Reference-Cited by-同舟云学术

ETC-1002 (Bempedoic acid) for the management of hyperlipidemia: from preclinical studies to phase 3 trials

Published:2019-02-27 Issue:7 Volume:20 Page:791-803
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Ruscica M.¹^ORCID,Banach M.²³,Sahebkar A.⁴⁵⁶^ORCID,Corsini A.¹⁷^ORCID,Sirtori C. R.⁸

Affiliation:

1. Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy

2. Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Lodz, Poland

3. Polish Mother’s Memorial Hospital Research Institute (PMMHRI), Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland

4. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

5. Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

6. School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

7. Multimedica IRCCS, Milan, Italy

8. Dyslipidemia Center, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy

Funder

the Fondazione Cariplo

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2019.1583209

Reference81 articles.

1. Prevention of cardiovascular disease: Much more is needed

2. Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart Disease

3. The pharmacology of statins

4. Practice-Level Variation in Statin Use Among Patients With Diabetes

5. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic coronary syndromes: diagnosis, management and gaps in evidence;Heart, Vessels and Transplantation;2024-08-28

2. Efficacy and Safety of Bempedoic Acid in Lipid Disorder Therapy: A Review of Clinical Trials;Prospects in Pharmaceutical Sciences;2024-08-18

3. Evolution of LDL-C lowering medications and their cardiovascular benefits: Past, present, and future;Current Problems in Cardiology;2024-07

4. ATP-Citrate Lyase (ACLY): An Extensive Investigation from Molecular Insight to Therapeutic implications;Natural Resources for Human Health;2024-06-05

5. Discovery and characterization of novel ATP citrate lyase inhibitors from Acanthopanax senticosus (Rupr. & Maxim.) Harms;Fitoterapia;2024-06